Overview


The enzyme-linked immunosorbent assay (ELISA) is a test that can be used to see if there are antibodies in a biological liquid sample. ELISA is employed as a quality control check as well as a diagnostic tool in plant pathology and medicine in a variety of industries. Buying an ELISA development system kit instead of a ready-to-use ELISA or individual antibodies is a more cost-effective and reliable option. ELISA tests are routinely used to diagnose a wide range of chronic and infectious diseases. The ELISA test can be used to diagnose HIV and AIDS. The World Health Organization (WHO) estimates that 37.7 million people will be HIV-positive by 2020. As a result, the increasing prevalence of HIV and AIDS is driving the industry ahead.
The complexity of proteins and their interactions, on the other hand, is expected to stymie the expansion of the enzyme linked immunosorbent assay (ELISA) development kits market throughout the forecast period. However, in the next years, the availability of a variety of different immunoassay methods may pose a significant threat to the growth of the enzyme linked immunosorbent assay (ELISA) development kits market.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Enzyme Linked Immunosorbent Assay (ELISA) Development Kits Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Enzyme Linked Immunosorbent Assay (ELISA) Development Kits Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Thermo Fisher Scientific
  • Mabtech
  • R D Systems, Inc.
  • PeproTech, Inc.
  • PromoCell GmbH
  • Epitope Diagnostics, Inc.
  • SBH Sciences
  • LifeSpan BioSciences, Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product Type

  • People ELISA Kits
  • Animal ELISA Kits

By Industry

  • Laboratory
  • Testing Institutions
  • Hospital
  • Other

By Distribution Channel

  • Direct Sales
  • Distributor

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Enzyme Linked Immunosorbent Assay (ELISA) Development Kits Market By Product Type, By Industry, By Distribution Channel and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- Product Type launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Enzyme Linked Immunosorbent Assay (ELISA) Development Kits Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Enzyme Linked Immunosorbent Assay (ELISA) Development Kits Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Enzyme Linked Immunosorbent Assay (ELISA) Development Kits Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Enzyme Linked Immunosorbent Assay (ELISA) Development Kits Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. People ELISA Kits
        2. Animal ELISA Kits

  • 8.   Enzyme Linked Immunosorbent Assay (ELISA) Development Kits Market, By Industry Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Laboratory
        2. Testing Institutions
        3. Hospital
        4. Other

  • 9.   Enzyme Linked Immunosorbent Assay (ELISA) Development Kits Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Direct Sales
        2. Distributor

  • 10.   North America Enzyme Linked Immunosorbent Assay (ELISA) Development Kits Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Enzyme Linked Immunosorbent Assay (ELISA) Development Kits Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Enzyme Linked Immunosorbent Assay (ELISA) Development Kits Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Enzyme Linked Immunosorbent Assay (ELISA) Development Kits Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Types Offered and Financial Layouts)
    •   1. Thermo Fisher Scientific
         1.1. Company Overview
         1.2. Product Type Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Mabtech
         2.1. Company Overview
         2.2. Product Type Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. R D Systems, Inc.
         3.1. Company Overview
         3.2. Product Type Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. PeproTech, Inc.
         4.1. Company Overview
         4.2. Product Type Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. PromoCell GmbH
         5.1. Company Overview
         5.2. Product Type Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Epitope Diagnostics, Inc.
         6.1. Company Overview
         6.2. Product Type Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. SBH Sciences
         7.1. Company Overview
         7.2. Product Type Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. LifeSpan BioSciences, Inc
         8.1. Company Overview
         8.2. Product Type Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare
                   administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients